Biotechnology News

May 29, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at three investment conferences during June 2012. Information regarding these conferences is provided below: Jefferies 2012...

May 29, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina (NASDAQ:ILMN) today announced that the Queensland Centre for Medical Genomics (QCMG), home of Australia’s International Cancer Genomics Consortium program, has established Illumina technology as its core...

May 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5, 2012 at 3:00 p.m. (ET) in...

May 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--drug discovery collaboration with Genentech to discover macrocyclic drug candidates against targets specified by Genentech

May 29, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Cure for Traumatic Brain Injury May be in Sight

May 29, 2012

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ:SNTS) today announced that Gerald T. Proehl, president and chief executive officer, will make a presentation at the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5, 2012, at 2:30 p...

May 29, 2012

GATWICK, England--(BUSINESS WIRE)--Consensus launched at European Wound Management Association's (EWMA) conference reveals guidelines on proper use of silver wound dressings

May 29, 2012

HAMBURG, Germany & CARLSBAD, Calif.--(BUSINESS WIRE)--European framework agreement outlining the terms for distribution by Olympus subsidiaries in Europe of ASI's GenASIs automated imaging platforms for genetic and pathological analysis.

May 29, 2012

TUSTIN, Calif.--(BUSINESS WIRE)--When opening a new hospital or medical center, partnering with the right diagnostic imaging vendor with patient-focused technology and a trusted, responsive service and support team is critical to meet the tight...

May 29, 2012

HATFIELD, United Kingdom--(BUSINESS WIRE)--EMA's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Fycompa® (perampanel) as an adjunctive treatment of partial-onset seizure

May 28, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) announced today that it will present at the Jefferies 2012 Global Healthcare Conference on Monday, June 4th at 9:30am Eastern Daylight Time (EDT), 2:30pm British Summer Time (BST)....

May 28, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Entrepreneurs with startups or business plans serving the baby boomer market are invited to apply to the 9th annual Silicon Valley Boomer Venture Summit and Business Plan Competition at SCU June 20.

May 28, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics (STO:PREC) is pleased to announce that Etienne Veber has joined Precise Biometrics in the capacity of Chief Commercial Officer and Executive Vice President. He comes on board as part...

May 28, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics' (http://www.precisebiometrics.com)(STO:PREC) product for mobile security for smartphones and...

May 26, 2012

PHILADELPHIA--(BUSINESS WIRE)--Pre-diabetic patients who engage in regular aerobic exercise improve their vascular reactivity to nearly normal levels, even if no weight loss is achieved, according to research presented today at the American...

May 25, 2012

SEATTLE--(BUSINESS WIRE)--May 25, 2012--Dendreon Corporation (NASDAQ:DNDN) today announced that management will present at the following conferences: Jefferies 2012 Global Healthcare Conference in New York City on June 4, 2012, at 12:30 p.m. ET...

May 25, 2012

DUARTE, Calif.--(BUSINESS WIRE)--City of Hope has been awarded a $5 million grant to support the development of a T cell-based immunotherapy that re-directs a patient’s own immune response against glioma stem cells.

May 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that the Company will be conducting a webcast of the...

May 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex announces webcasts of its presentations at two investor conferences.

May 25, 2012

WASHINGTON--(BUSINESS WIRE)--BIO supports EPA's rejection of a petroleum industry petition to retroactively waive the 2011 Renewable Fuel Standard. The oil industry is using regulatory obstacles to keep the US dependent on oil.

May 25, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to provide insight on the upcoming release of its’ new over-the-...

May 25, 2012

LUXEMBOURG--(BUSINESS WIRE)--ABL Clinical Genotyping Solutions for Sanger Sequencing and Next Generation Sequencing (NGS) received CE-mark for in vitro diagnostic (IVD) use according latest medical devices directives

May 25, 2012

READING, United Kingdom--(BUSINESS WIRE)--Quintiles ranks number 4 in the Great Place to Work Institute rankings for 2012

May 25, 2012

IRVINE, Calif. & LIEGE, Belgium--(BUSINESS WIRE)--Regulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, held its Annual and...

May 25, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union...

May 25, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics Appoints Dr. Keith B. Jarrett to Board of Directors; His extensive experiences with multi-stage technology firms, capital mgmt. processes and strategic M&A are invaluable...

May 25, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) will hold its Annual Meeting of Stockholders at 10:00 a.m. Pacific Time on Thursday, May 31, 2012 at the company's headquarters at 965 Atlantic Avenue, Alameda, California...

May 25, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) reported that data showing that Thymosin beta 4 (Tβ4) “provides both neuroprotection and neurorestoration after traumatic...

May 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated announced today that the European CHMP has issued a positive opinion recommending the approval of KALYDECO for people with CF 6 and older with the G551D mutation.

May 25, 2012

KIGALI, Rwanda--(BUSINESS WIRE)--Rwanda today accelerated its fight against rotavirus, the primary cause of deadly diarrhea in young children, when it became the fourth African country to introduce new rotavirus vaccines only recently made...

May 25, 2012

NEW YORK--(BUSINESS WIRE)--Fera Pharmaceuticals is pleased to announce availability of Methazolamide Tablets and plans to commence shipping June 1, 2012. “Methazolamide has been in short supply in the US and Fera has been working diligently to...

May 25, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Orexo AB (STO:ORX) announced today that accumulated sales of Abstral has surpassed 65 MEUR, which was faster than earlier anticipated and results in a 3.3 MEUR milestone payment from ProStrakan....

May 25, 2012

PARIS--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) today announced results from two large, international multicenter trials demonstrating that a low glucose peritoneal dialysis (PD) regimen favorably impacted metabolic measures...

May 24, 2012

HENDERSON, Nev. & WESTMINSTER, Colo.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) (Spectrum) and Allos Therapeutics, Inc. (NasdaqGS: ALTH) (Allos) today announced that Spectrum has provided an additional extension of the...

May 24, 2012

WASHINGTON--(BUSINESS WIRE)--A group of biofuel, airline industry, farm and national security groups expressed disappointment in the Senate Armed Services Committee's support of amendments blocking military use of biofuels.

May 24, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Zurich Heart Center Presents Clinical Experience with eSVS® Mesh at International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting

May 24, 2012

WASHINGTON--(BUSINESS WIRE)--Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement in support of the U.S. Senate’s approval of the Food and Drug Administration Safety and Innovation Act (FDASIA...

May 24, 2012

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Health Canada has authorized for marketing a new source plasma collection system developed by Fenwal Inc.

May 24, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) applauds Senator Robert Menendez (D-NJ) for introducing the “The Extension of the Therapeutic Discovery Project Tax Credit” (S. 3232), which will extend and improve the...

May 24, 2012

AUSTIN, Texas--(BUSINESS WIRE)--Microorganism ID bacterial identification service from Altogen Labs CRO.

May 24, 2012

MILWAUKEE, Wis. & ANDOVER, Mass.--(BUSINESS WIRE)--GE Healthcare (NYSE: GE) and Royal Philips Electronics (AEX: PHI, NYSE: PHG) applaud the Federal Communications Commission (FCC) today for its action allocating protected spectrum for...

May 24, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR) has been named as the winner of the 2012 SwedenBIO Award. The prize is awarded by SwedenBIO, which is an association of member companies with the aim of promoting growth in...

May 24, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological...

May 24, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--RetroSense Therapeutics, a gene therapy company dedicated to vision restoration, announced completion of a pre-IND meeting with the Center for Biological Evaluation and Research (CBER) division of the FDA that...

May 24, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) the manufacturer of KALBITOR® (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older, has announced the launch of its HAE...

May 24, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--Dynasil Corporation of America (NASDAQ: DYSL) today announced that it has entered into a technology collaboration agreement with Mayo Clinic, a not-for-profit worldwide leader in medical care, research and...

May 24, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Take Part in Sanford Bernstein’s 28th Annual Strategic Decisions Conference